<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Infect Dis</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Infect. Dis</journal-id>
      <journal-title-group>
        <journal-title>BMC Infectious Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2334</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26499862</article-id>
      <article-id pub-id-type="pmc">4619209</article-id>
      <article-id pub-id-type="publisher-id">1191</article-id>
      <article-id pub-id-type="doi">10.1186/s12879-015-1191-6</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Spontaneous remission of fully symptomatic visceral leishmaniasis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" equal-contrib="yes">
          <name>
            <surname>Mouri</surname>
            <given-names>Oussama</given-names>
          </name>
          <address>
            <phone>33 1 42 16 02 43 48</phone>
            <email>oussama.mouri@psl.aphp.fr</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Benhamou</surname>
            <given-names>Mathilde</given-names>
          </name>
          <address>
            <email>mathilde.benhamou@aphp.fr</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Leroux</surname>
            <given-names>Ga&#xEB;lle</given-names>
          </name>
          <address>
            <email>gaelle.leroux@aphp.fr</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chartrel</surname>
            <given-names>Nathalie</given-names>
          </name>
          <address>
            <email>nathaliechartrel@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Devidas</surname>
            <given-names>Alain</given-names>
          </name>
          <address>
            <email>alain.devidas@ch-sud-francilien.fr</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Thellier</surname>
            <given-names>Marc</given-names>
          </name>
          <address>
            <email>marc.thellier@psl.aphp.fr</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff6"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Amoura</surname>
            <given-names>Zahir</given-names>
          </name>
          <address>
            <email>zahir.amoura@aphp.fr</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Costedoat-Chalumeau</surname>
            <given-names>Nathalie</given-names>
          </name>
          <address>
            <email>nathalie.costedoat@aphp.fr</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Buffet</surname>
            <given-names>Pierre</given-names>
          </name>
          <address>
            <email>pabuffet@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff6"/>
        </contrib>
        <aff id="Aff1"><label/>AP-HP, H&#xF4;pital Piti&#xE9;-Salp&#xEA;tri&#xE8;re, Service de Parasitologie, F-75013 Paris, France </aff>
        <aff id="Aff2"><label/>AP-HP, H&#xF4;pital Piti&#xE9;-Salp&#xEA;tri&#xE8;re, Service de M&#xE9;decine Interne, F-75013 Paris, France </aff>
        <aff id="Aff3"><label/>AP-HP, H&#xF4;pital Cochin, Service de M&#xE9;decine Interne. Centre de r&#xE9;f&#xE9;rence maladies auto-immunes et syst&#xE9;miques rares, Service de M&#xE9;decine Interne, F-75014 Paris, France </aff>
        <aff id="Aff4"><label/>Hopital Sud Francilien, Service d&#x2019;H&#xE9;matologie, Corbeil-Essonnes, France </aff>
        <aff id="Aff5"><label/>AP-HP, H&#xF4;pital Cochin, Service de R&#xE9;&#xE9;ducation et R&#xE9;adaptation, F-75014 Paris, France </aff>
        <aff id="Aff6"><label/>UPMC Universit&#xE9; Paris 06, Centre Immunologie et Maladies Infectieuses, F-75005 Paris, France </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>23</day>
        <month>10</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>23</day>
        <month>10</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>15</volume>
      <elocation-id>445</elocation-id>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>4</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>7</day>
          <month>10</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Mouri et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Visceral leishmaniasis (VL), i.e., infection with <italic>Leishmania sp.</italic> associated with high fever, weight loss, massive splenomegaly and markedly altered laboratory parameters, is generally fatal if untreated. The possibility of transient spontaneous remission of fully symptomatic visceral leishmaniasis (VL) has been mentioned but, to our knowledge) has never been documented.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>We report the first documented history of a patient with overt, confirmed VL experiencing a complete remission in the absence of any anti-leishmanial therapy. The diagnosis of VL at the time of the self-resolving episode was strongly suspected based on clinical presentation and presence of antileishmanial antibody, then unequivocally confirmed years later by the presence of an amastigote on a stored smear and the positive quantitative PCR with <italic>Leishmania</italic>-specific primers from the material scraped from this same slide</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>This report demonstrates that complete spontaneous remission may occur in patients with overt, fully symptomatic VL. VL should therefore be considered in cases of self-resolving or relapsing episodes of fever of unknown origin. Confirmation should be based on both serological tests and specific PCR on a blood sample.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Visceral leishmaniasis</kwd>
        <kwd>Spontaneous remission</kwd>
        <kwd>Hemophagocytic lymphohistiocytosis</kwd>
        <kwd>Real time PCR</kwd>
        <kwd>Giemsa stained</kwd>
        <kwd>Bone marrow smear</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Overt visceral leishmaniasis, i.e., infection with <italic>Leishmania sp.</italic> associated with high fever, weight loss, massive splenomegaly and markedly altered laboratory parameters, is generally considered fatal if untreated [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. The possibility of transient spontaneous remission has been mentioned [<xref ref-type="bibr" rid="CR3">3</xref>] but, to our knowledge, has never been precisely documented because patients with documented VL are treated. We provide the first description of a complete, prolonged remission of fully symptomatic VL in a patient who had not received any anti-leishmanial therapy.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>In July 2008, a 27-year-old immunocompetent male patient was referred to our hospital for a 3-week history of fever, asthenia and pancytopenia. The patient had spent 4&#xA0;month in an area endemic for <italic>Leishmania infantum</italic> in the South of France (Oriental Pyrennees). His medical history included dental infections and an allergy to methicillin. He reported two similar episodes of high fever and asthenia in 2006 (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). The first episode in June 2006 had resolved spontaneously. During the second episode, in November, the patient was hospitalized with splenomegaly (17&#xA0;cm), fever (40&#xA0;&#xB0;C) and weight loss (10&#xA0;kg), anemia, leucopenia and thrombocytopenia (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). Microscopic examination of a bone marrow (BM) aspirate was negative for parasites<italic>.</italic> The bone marrow smear showed normal cellularity and there was no indication of immunosuppression. All microbiological and immunological tests were negative (blood and urine culture, testing for HIV, salmonella, brucellosis, Lyme borreliosis, hepatitis A, cytomegalovirus infection, arboviral infection, and malaria) except for positive titers of anti-<italic>Leishmania</italic> antibody (IFA 1/400) and a positive serology for EBV suggestive of prior infection. In this context of fever of unknown origin, a presumptive 8-day course of intravenous antibiotic therapy (ceftriaxone and ofloxacin) was administered. All signs and symptoms, including fever, splenomegaly and asthenia, resolved in 4&#xA0;weeks. No specific anti-leishmanial drug had been administered, as the treating physician had not retained this diagnosis<italic>.</italic> All laboratory parameters normalized during the same period, confirming complete remission of the episode (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>&#x115F;</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>2006 Nov. 13th</th><th>2007, Feb. 1st</th><th>2008, July 2nd</th><th>2008, July 11th</th><th>2008, July 21st</th><th>2009, Jan. 15th</th></tr></thead><tbody><tr><td>Antileishmanial agent</td><td/><td/><td/><td>L-AmB Day1</td><td>L-AmB Day10</td><td/></tr><tr><td>Antimicrobial agents</td><td>Ciprofloxacin ceftriaxone</td><td/><td/><td/><td/><td/></tr><tr><td>Clinical parameters</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Temperature (&#xB0;C)</td><td>40</td><td>37</td><td>40</td><td>38.2</td><td>36.1</td><td>36.5</td></tr><tr><td>Weight (kg)</td><td>59</td><td>73</td><td>68</td><td/><td/><td>72</td></tr><tr><td>Biological parameters</td><td/><td/><td/><td/><td/><td/></tr><tr><td>White blood cell count (/mL)</td><td>1.480</td><td>7.000</td><td>1.280</td><td>0.990</td><td>4.110</td><td>9.200</td></tr><tr><td>Neutrophils (/mL)</td><td>0.720</td><td>4.018</td><td>0.563</td><td>0.495</td><td>1.993</td><td>6.522</td></tr><tr><td>Lymphocytes (/mL)</td><td>0.650</td><td>2.065</td><td>0.640</td><td>0.455</td><td>1.780</td><td>1.536</td></tr><tr><td>Hemoglobin (g/dL)</td><td>9.6</td><td>14.8</td><td>9.9</td><td>9.1</td><td>11.6</td><td>16.2</td></tr><tr><td>Platelet count (/mL)</td><td>87.000</td><td>197.000</td><td>75.000</td><td>64.000</td><td>250.000</td><td>182.000</td></tr><tr><td>ASAT (IU/L)</td><td>126</td><td>21</td><td>51</td><td>93</td><td/><td>20</td></tr><tr><td>ALAT (IU/L)</td><td>56</td><td>18</td><td>15</td><td>19</td><td/><td>17</td></tr><tr><td>C-reactive protein (mg/L)</td><td>160</td><td>1.9</td><td>63</td><td>97</td><td>4</td><td/></tr><tr><td>Ferritin (&#x3BC;g/L)</td><td>19.295</td><td>57</td><td>2.093</td><td/><td/><td/></tr><tr><td>Fibrinogen (g/l)</td><td>2.5</td><td>3.5</td><td>3.5</td><td/><td/><td/></tr><tr><td>Triglycerides (mmol/L)</td><td>2.32</td><td/><td>2.21</td><td/><td/><td/></tr><tr><td>LDH (IU/L)</td><td>1.400</td><td>250</td><td>1.010</td><td/><td/><td/></tr></tbody></table></table-wrap></p>
      <p>In 2008, relapse occurred with weight loss (4&#xA0;kg), fever (40&#xA0;&#xB0;C) and arthralgia (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). Physical examination showed an enlarged spleen, measuring 20&#xA0;cm on the subsequent CT scan. Antinuclear antibodies were positive (dilution of 1/1280) with a nonspecific pattern. The bone marrow (BM) aspirate showed hemophagocytosis. All microbiological tests, including <italic>Histoplasma capsulatum</italic> antibody were negative except anti-leishmanial antibody titers that were again positive (ELISA &gt;1.7 for a threshold at 1)<italic>.</italic> Quantitative polymerase chain reaction (PCR) on a <italic>L. infantum</italic> kinetoplast DNA target found 30 parasites per mL, i.e., above the threshold for active VL (1 parasite/ml) [<xref ref-type="bibr" rid="CR4">4</xref>]. Blood and BM cultures for <italic>L. infantum</italic> were negative.</p>
      <p>Fever lasted 4&#xA0;weeks before the diagnosis of VL was confirmed. The patient was then treated with liposomal Amphotericin B (l-AmB) (3&#xA0;mg/kg/day D1-5 and D10) [<xref ref-type="bibr" rid="CR5">5</xref>]. Complete fever resolution was obtained in 3&#xA0;days along with a dramatic improvement of the patient&#x2019;s general well-being. Ultrasonography showed regression of splenomegaly from 20 to 14&#xA0;cm at the end of the first week, followed by normalization to 12&#xA0;cm 6&#xA0;months later. At that time laboratory parameters had returned to normal levels (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>) and quantitative PCR for <italic>L. infantum</italic> was negative. When last seen, in September 2010, the patient was completely asymptomatic.</p>
      <p>We reexamined a bone marrow smear performed in 2006 during the first hospitalization. Independent, complete examination of this smear by 2 observers (10&#xA0;h of observation under the microscope) revealed the presence of a single typical amastigote form of <italic>Leishmania</italic> sp. (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). Material on the smear was then thoroughly scarped from the slide with a blade and resuspended in 30&#xA0;&#x3BC;l of sterile distilled water. Real time PCR amplification was performed in a thermal cycler TAQMAN&#xAE; (Applied Biosystems) using Leishmania kDNA specific primers as described by Mary et al. [<xref ref-type="bibr" rid="CR4">4</xref>]. One negative blood slide and one negative tissue slide were used as controls. Amplification of the material retrieved from the slide occurred at 28 CTs, corresponding to the presence of 1.8 parasites (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig 1</label><caption><p>Amplification profile in RT-PCR of the Giemsa slide of the bone marrow smear, the negative blood slide and the negative tissue slide, the amplification of the <italic>Leishmania</italic> kinetoplast DNA is labeled in orange and the amplification of the DNA of the Internal Positive Control (IPC) is labeled in Grey. The amplification of the kinetoplast DNA of <italic>Leishmania</italic> from the Giemsa slide of the bone marrow smear is indicated by red vertical dotted line and occurred at 28 CTs which corresponds to the presence of 1.8 parasites on the slide. The amplification of the kinetoplast DNA of <italic>Leishmania</italic> from the five positive points of the range are indicated by blue vertical dotted lines. Typical amastigote form of <italic>Leishmania sp</italic> (2&#x2013;3&#xA0;mm in diameter) seen in smear bone marrow shown in insert squares at the left side of the figure. The nucleus and kinetoplast are in red arrow. Staining May Grunwald Giemsa (MGG) x1000. *Parasite</p></caption><graphic xlink:href="12879_2015_1191_Fig1_HTML" id="MO1"/></fig></p>
    </sec>
    <sec id="Sec3">
      <title>Discussion</title>
      <p>This is the first documented report of a patient with overt, confirmed VL experiencing a complete remission in the absence of any anti-leishmanial therapy. The diagnosis of VL at the time of the self-resolving episode was strongly suspected based on clinical presentation and presence of antileishmanial antibody, then unequivocally confirmed years later by the presence of an amastigote on a stored smear. Quantitative PCR from the material scraped from this same slide using <italic>Leishmania</italic>-specific primers was positive. The excellent specificity of this PCR has been confirmed by several teams [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR6">6</xref>&#x2013;<xref ref-type="bibr" rid="CR9">9</xref>]. The last episode, during which PCR was positive in a blood sample was followed by a positive outcome under anti-leishmanial therapy with liposomal amphotericin B. No relapse occurred during the 2&#xA0;years following administration of anti-leishmanial therapy, which is consistent with the high efficacy of l-AmB in Mediterranean VL [<xref ref-type="bibr" rid="CR10">10</xref>].</p>
      <p>It has been known for decades that patients with mild symptoms of VL may recover spontaneously and that a minority eventually develop overt clinical VL [<xref ref-type="bibr" rid="CR11">11</xref>]. In <italic>L. infantum</italic> transmission foci, asymptomatic infections and mild clinical forms of VL are indeed frequent in humans [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. This is different from the spontaneous remission of fully symptomatic severe VL, as described here. Uncontrolled studies that show improvement or apparent cure in patients receiving experimental anti-leishmanial interventions for overt VL should thus be interpreted cautiously [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. We cannot definitely exclude the hypothesis that the short course of intravenous antibiotic therapy (ceftriaxone and ofloxacin during 8&#xA0;days) during the first episode may have contributed to the patient's improvement. A few reports in vitro or in animals suggest indeed that quinolones may have some activity against <italic>Leishmania</italic> [<xref ref-type="bibr" rid="CR16">16</xref>&#x2013;<xref ref-type="bibr" rid="CR18">18</xref>] thus possibly contributing to the control of parasite loads. Thereafter, the patient was appropriately treated and cured with liposomal Amphotericin B.</p>
      <p>For confirmation of VL, PCR in the blood is more sensitive than conventional search of the parasite even in bone marrow aspirates. Time spent for reading Giemsa-stained smears in the search for <italic>Leishmania</italic> amastigotes increases the test sensitivity that raises to 95.4&#xA0;% after 60&#xA0;min and 89.7&#xA0;% when 1.200 fields are examined [<xref ref-type="bibr" rid="CR19">19</xref>]. When a macrophage activation syndrome is present, repetition of bone marrow aspirates also increases diagnostic sensitivity [<xref ref-type="bibr" rid="CR20">20</xref>]. Why patients would spontaneously recover from overt VL is not clear. Interestingly, our patient met five out of the eight criteria of the hemophagocytic lymphohistiocytosis (HLH-2004 revised diagnostic guidelines) [<xref ref-type="bibr" rid="CR21">21</xref>]. Therefore, if HLH had also occurred during the initial episode, phagocytosis of <italic>Leishmania</italic>-infected cells by previously activated macrophages, or a general activation of macrophages as observed in HLH, may have contributed to the control of parasite loads. This hypothesis is consistent with the absence of <italic>Leishmania</italic> amastigotes in bone marrow aspirates in 36.3&#xA0;% of patients with VL and HLH [<xref ref-type="bibr" rid="CR22">22</xref>].</p>
    </sec>
    <sec id="Sec4">
      <title>Conclusion</title>
      <p>In summary, this report demonstrates that complete spontaneous remission may occur in patients with overt, fully symptomatic VL. VL should therefore be considered in cases of self-resolving or relapsing episodes of fever of unknown origin. Confirmation should be based on both serological tests and specific PCR on a blood sample.</p>
    </sec>
    <sec id="Sec5">
      <title>Consent</title>
      <p>Patient was informed of the process by this attending physician using a procedure common to all French National Reference Centers (NRC) (<ext-link ext-link-type="uri" xlink:href="http://www.parasitologie.univ-montp1.fr/conseil.htm">http://www.parasitologie.univ-montp1.fr/conseil.htm</ext-link>) and gave his oral consent for data collection and publication. Mention of this consent was written in the medical chart.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>VL</term>
          <def>
            <p>Visceral leishmaniasis</p>
          </def>
        </def-item>
        <def-item>
          <term>PCR</term>
          <def>
            <p>Polymerase chain reaction</p>
          </def>
        </def-item>
        <def-item>
          <term>HIV</term>
          <def>
            <p>Human immunodeficiency virus</p>
          </def>
        </def-item>
        <def-item>
          <term>EBV</term>
          <def>
            <p>Epstein-barr virus</p>
          </def>
        </def-item>
        <def-item>
          <term>HLH</term>
          <def>
            <p>Hemophagocytic lymphohistiocytosis</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>Oussama Mouri, Mathilde Benhamou, Nathalie Costedoat-Chalumeau and Pierre Buffet contributed equally to this work.</p>
      </fn>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>PB NCC OM ZA AD have made the diagnosis and contributed to patient care. PB ZA GL AD have designed the analysis. PB OM NCC MB MT wrote the paper. NC MT have contributed vital samples/information/materials/tools. All authors read and approved the final version.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank nurses and technicians from the medical department and the clinical laboratory for their outstanding contribution to the management of patient. This work was not supported by any external funding.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Pearson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>de Queiroz Sousa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jeronimo</surname>
              <given-names>SB</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Mandell</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Bennett</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Dolin</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Leishmania species: visceral (Kala-Azar), cutaneous and mucosal leishmaniasis</article-title>
          <source>Mandell, Douglas, and Bennett's Principles and practice of infectious diseases. Volume 2</source>
          <year>2000</year>
          <publisher-loc>Philadelphia</publisher-loc>
          <publisher-name>Churchill Linvingstone</publisher-name>
          <fpage>2831</fpage>
          <lpage>2845</lpage>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>den Boer</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Alvar</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Davidson</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Ritmeijer</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Balasegaram</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Developments in the treatment of visceral leishmaniasis</article-title>
          <source>Expert Opin Emerg Drugs</source>
          <year>2009</year>
          <volume>14</volume>
          <issue>3</issue>
          <fpage>395</fpage>
          <lpage>410</lpage>
          <pub-id pub-id-type="doi">10.1517/14728210903153862</pub-id>
          <pub-id pub-id-type="pmid">19708817</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bern</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Maguire</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Alvar</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Complexities of assessing the disease burden attributable to leishmaniasis</article-title>
          <source>PLoS Negl Trop Dis</source>
          <year>2008</year>
          <volume>2</volume>
          <issue>10</issue>
          <pub-id pub-id-type="doi">10.1371/journal.pntd.0000313</pub-id>
          <pub-id pub-id-type="pmid">18958165</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mary</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Faraut</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Lascombe</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Dumon</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity</article-title>
          <source>J Clin Microbiol</source>
          <year>2004</year>
          <volume>42</volume>
          <issue>11</issue>
          <fpage>5249</fpage>
          <lpage>5255</lpage>
          <pub-id pub-id-type="doi">10.1128/JCM.42.11.5249-5255.2004</pub-id>
          <pub-id pub-id-type="pmid">15528722</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davidson</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>di Martino</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Gradoni</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Giacchino</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gaeta</surname>
              <given-names>GB</given-names>
            </name>
            <name>
              <surname>Pempinello</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Scotti</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cascio</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Castagnola</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Maisto</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome)</article-title>
          <source>Clin Infect Dis</source>
          <year>1996</year>
          <volume>22</volume>
          <issue>6</issue>
          <fpage>938</fpage>
          <lpage>943</lpage>
          <pub-id pub-id-type="doi">10.1093/clinids/22.6.938</pub-id>
          <pub-id pub-id-type="pmid">8783690</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brustoloni</surname>
              <given-names>YM</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>da Cunha</surname>
              <given-names>RV</given-names>
            </name>
            <name>
              <surname>Dorval</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Oshiro</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>de Oliveira</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Pirmez</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Sensitivity and specificity of polymerase chain reaction in Giemsa-stained slides for diagnosis of visceral leishmaniasis in children</article-title>
          <source>Mem Inst Oswaldo Cruz</source>
          <year>2007</year>
          <volume>102</volume>
          <issue>4</issue>
          <fpage>497</fpage>
          <lpage>500</lpage>
          <pub-id pub-id-type="doi">10.1590/S0074-02762007005000036</pub-id>
          <pub-id pub-id-type="pmid">17612771</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fisa</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Riera</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lopez-Chejade</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Molina</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Gallego</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Falco</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Ribera</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Portus</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Leishmania infantum DNA detection in urine from patients with visceral leishmaniasis and after treatment control</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>2008</year>
          <volume>78</volume>
          <issue>5</issue>
          <fpage>741</fpage>
          <lpage>744</lpage>
          <pub-id pub-id-type="pmid">18458307</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ozerdem</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Eroglu</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Genc</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Demirkazik</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Koltas</surname>
              <given-names>IS</given-names>
            </name>
          </person-group>
          <article-title>Comparison of microscopic examination, rK39, and PCR for visceral leishmaniasis diagnosis in Turkey</article-title>
          <source>Parasitol Res</source>
          <year>2009</year>
          <volume>106</volume>
          <issue>1</issue>
          <fpage>197</fpage>
          <lpage>200</lpage>
          <pub-id pub-id-type="doi">10.1007/s00436-009-1650-3</pub-id>
          <pub-id pub-id-type="pmid">19859739</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fraga</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Brustoloni</surname>
              <given-names>YM</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Dorval</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Oshiro</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Pirmez</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Polymerase chain reaction of peripheral blood as a tool for the diagnosis of visceral leishmaniasis in children</article-title>
          <source>Mem Inst Oswaldo Cruz</source>
          <year>2010</year>
          <volume>105</volume>
          <issue>3</issue>
          <fpage>310</fpage>
          <lpage>313</lpage>
          <pub-id pub-id-type="doi">10.1590/S0074-02762010000300011</pub-id>
          <pub-id pub-id-type="pmid">20512245</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gradoni</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Soteriadou</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Louzir</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Dakkak</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Toz</surname>
              <given-names>SO</given-names>
            </name>
            <name>
              <surname>Jaffe</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Dedet</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Campino</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Canavate</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Dujardin</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Drug regimens for visceral leishmaniasis in Mediterranean countries</article-title>
          <source>Trop Med Int Health</source>
          <year>2008</year>
          <volume>13</volume>
          <issue>10</issue>
          <fpage>1272</fpage>
          <lpage>1276</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-3156.2008.02144.x</pub-id>
          <pub-id pub-id-type="pmid">18764817</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Evans</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Teixeira</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Sousa Ade</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Pearson</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <article-title>Short report: extended follow-up of the natural history of persons infected with Leishmania chagasi</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>1995</year>
          <volume>53</volume>
          <issue>4</issue>
          <fpage>360</fpage>
          <lpage>361</lpage>
          <pub-id pub-id-type="pmid">7485687</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Badaro</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Sampaio</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Reed</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Barral</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Teixeira</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>WD</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>New perspectives on a subclinical form of visceral leishmaniasis</article-title>
          <source>J Infect Dis</source>
          <year>1986</year>
          <volume>154</volume>
          <issue>6</issue>
          <fpage>1003</fpage>
          <lpage>1011</lpage>
          <pub-id pub-id-type="doi">10.1093/infdis/154.6.1003</pub-id>
          <pub-id pub-id-type="pmid">3782864</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jeronimo</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Teixeira</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Sousa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Thielking</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pearson</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>TG</given-names>
            </name>
          </person-group>
          <article-title>Natural history of Leishmania (Leishmania) chagasi infection in Northeastern Brazil: long-term follow-up</article-title>
          <source>Clin Infect Dis</source>
          <year>2000</year>
          <volume>30</volume>
          <issue>3</issue>
          <fpage>608</fpage>
          <lpage>609</lpage>
          <pub-id pub-id-type="doi">10.1086/313697</pub-id>
          <pub-id pub-id-type="pmid">10722458</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jha</surname>
              <given-names>TK</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of diamidine compound (pentamidine isethionate) in the treatment resistant cases of kala-azar occurring in North Bihar, India</article-title>
          <source>Trans R Soc Trop Med Hyg</source>
          <year>1983</year>
          <volume>77</volume>
          <issue>2</issue>
          <fpage>167</fpage>
          <lpage>170</lpage>
          <pub-id pub-id-type="doi">10.1016/0035-9203(83)90058-5</pub-id>
          <pub-id pub-id-type="pmid">6868096</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sundar</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>HW</given-names>
            </name>
          </person-group>
          <article-title>Gamma interferon in the treatment of Kala-azar and other forms of Leishmaniasis</article-title>
          <source>J Assoc Physicians India</source>
          <year>1995</year>
          <volume>43</volume>
          <issue>5</issue>
          <fpage>348</fpage>
          <lpage>350</lpage>
          <pub-id pub-id-type="pmid">9081967</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Romero</surname>
              <given-names>IC</given-names>
            </name>
            <name>
              <surname>Saravia</surname>
              <given-names>NG</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Selective action of fluoroquinolones against intracellular amastigotes of Leishmania (Viannia) panamensis in vitro</article-title>
          <source>J Parasitol</source>
          <year>2005</year>
          <volume>91</volume>
          <issue>6</issue>
          <fpage>1474</fpage>
          <lpage>1479</lpage>
          <pub-id pub-id-type="doi">10.1645/GE-3489.1</pub-id>
          <pub-id pub-id-type="pmid">16539034</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bianciardi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Fasanella</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Foglia Manzillo</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Trotta</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Pagano</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sorino</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gradoni</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Oliva</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>The efficacy of enrofloxacin, alone or combined with metronidazole, in the therapy of canine leishmaniasis</article-title>
          <source>Parasitol Res</source>
          <year>2004</year>
          <volume>93</volume>
          <issue>6</issue>
          <fpage>486</fpage>
          <lpage>492</lpage>
          <pub-id pub-id-type="doi">10.1007/s00436-004-1170-0</pub-id>
          <pub-id pub-id-type="pmid">15278443</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cortazar</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Coombs</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Leishmania panamensis: comparative inhibition of nuclear DNA topoisomerase II enzymes from promastigotes and human macrophages reveals anti-parasite selectivity of fluoroquinolones, flavonoids and pentamidine</article-title>
          <source>Exp Parasitol</source>
          <year>2007</year>
          <volume>116</volume>
          <issue>4</issue>
          <fpage>475</fpage>
          <lpage>482</lpage>
          <pub-id pub-id-type="doi">10.1016/j.exppara.2007.02.018</pub-id>
          <pub-id pub-id-type="pmid">17466980</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>da Silva</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Stewart</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>CH</given-names>
            </name>
          </person-group>
          <article-title>Sensitivity of bone marrow aspirates in the diagnosis of visceral leishmaniasis</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>2005</year>
          <volume>72</volume>
          <issue>6</issue>
          <fpage>811</fpage>
          <lpage>814</lpage>
          <pub-id pub-id-type="pmid">15964968</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gagnaire</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Galambrun</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Stephan</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Hemophagocytic syndrome: A misleading complication of visceral leishmaniasis in children--a series of 12 cases</article-title>
          <source>Pediatrics</source>
          <year>2000</year>
          <volume>106</volume>
          <issue>4</issue>
          <pub-id pub-id-type="doi">10.1542/peds.106.4.e58</pub-id>
          <pub-id pub-id-type="pmid">11015553</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henter</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Horne</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Arico</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Egeler</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Filipovich</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Imashuku</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ladisch</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>McClain</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Webb</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Winiarski</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis</article-title>
          <source>Pediatr Blood Cancer</source>
          <year>2007</year>
          <volume>48</volume>
          <issue>2</issue>
          <fpage>124</fpage>
          <lpage>131</lpage>
          <pub-id pub-id-type="doi">10.1002/pbc.21039</pub-id>
          <pub-id pub-id-type="pmid">16937360</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rajagopala</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dutta</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Chandra</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Bhatia</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Varma</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kochhar</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis--case report and systematic review</article-title>
          <source>J Infect</source>
          <year>2008</year>
          <volume>56</volume>
          <issue>5</issue>
          <fpage>381</fpage>
          <lpage>388</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jinf.2008.02.013</pub-id>
          <pub-id pub-id-type="pmid">18405976</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
